Global Imaging Reach RadMD operates as a global imaging CRO with sites in over 80 countries and access to a network of 300+ subspecialty radiologists, presenting cross-border collaboration and scalable imaging services for multinational clinical trials.

Full-Service iCRO Capabilities span from collect and hold to centralized reads, regulatory consulting, reader training, and imaging data management, enabling end-to-end support for Phase 1 to Phase 4 oncology trials and diverse therapeutic areas.

Pharma Access Point RadMD serves pharmaceutical and biotech clients, plus CROs, offering consistent imaging quality and regulatory-compliant workflows that can reduce risk and time-to-database lock for hard-to-image trials.

Scale and Specialization With a mid-market headcount and a revenue tier in the $25–50M range, RadMD presents as a nimble partner that can complement larger CROs and provide specialized radiology expertise for complex imaging endpoints.

Tech-Enabled Ops Leveraging AWS, Azure, Salesforce and related tools, RadMD can propose seamless technology-enabled data management, faster site activation, and integrated communications as a value-add for sponsors prioritizing digital transformation in imaging.